LITTLE KNOWN FACTS ABOUT DEPO 10.

Epidemiologic research and meta‑analyses have not observed a heightened risk of genital or non-genital start defects (such as cardiac anomalies and limb-reduction defects) next exposure to progestins in advance of conception or throughout early pregnancy.Anaphylaxis and anaphylactoid response have already been noted with using Depo-Provera CI. In